Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In a Phase I study with recombinant human thymosin beta-4, the terminal half-life was about 0.5 to 2.08 hours, for example 1.02 hours at 0.5 microg/kg and up to 2.08 hours at 25 microg/kg, with linear, non-accumulating kinetics and dose-proportional Cmax Wang et al., 2021
Sikiri's group were so struck that they proposed it might be the first of an entirely new class of medicines "a useful prototype of a new class of drugs," which they called organoprotective agents [9]
Strains to these tissues can cause significant pain and predispose the spine to further injury by compromising dynamic and static support mechanisms
Brain infarct volume was quantified at 21 days post-MCAO
Some areas of interest for this peptide include increasing insulin sensitivity, nerve pain, and heart, and cardiovascular disease among a few of the disease processes noted
